About this trial
The aim of this study is to investigate the relationship between trapezius muscle oxygenation and cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 18-65 years.
Chronic neck pain lasting for at least 3 months.
Neck pain intensity of ≥3 on the Visual Analog Scale during activity.
Willingness to participate in the study.
Disqualifiers
Motor deficit in the upper extremities.
History of cervical or upper-extremity surgery.
Rheumatologic or neurologic disease.
Any musculoskeletal condition affecting upper-extremity function.
Trial population
Adults aged 18-65 years with chronic neck pain lasting for at least 12 weeks who meet the study eligibility criteria.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Trapezius Muscle Oxygen Saturation
Trapezius muscle oxygen saturation will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise.
Trapezius Total Hemoglobin
Trapezius total hemoglobin will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise.
Secondary outcomes
Trapezius Muscle Strength
Upper and middle trapezius muscle strength will be measured using a handheld dynamometer.
Cervical Range of Motion
Active cervical flexion, extension, lateral flexion, and rotation will be measured using a goniometer.
Neck Disability
Disability will be assessed using the Neck Disability Index (NDI; 0-50 points), with higher scores indicating greater disability.
Upper-Extremity Exercise Capacity
Maximum upper-extremity exercise capacity will be assessed using an arm ergometer test, with peak workload recorded in watts.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: